EUCTR2005-003081-42-GBActive, not recruitingPhase 1
EXPLORING THE THERAPEUTIC POTENTIAL OF XANTHINE OXIDASE INHIBITORS IN CORONARY ARTERY DISEASE - allopurinol in CAD
niversity of DUndee0 sites124 target enrollmentStarted: July 25, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 124
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1) Stable angina pectoris with no heart failure
- •2) Acute MI
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Renal failure. Creatinine > 190mM/l
- •Contraindication to allopurinol (as per BNF)
Investigators
Similar Trials
Completed
Not Applicable
Exploring the therapeutic potential of xanthine oxidase inhibitor allopurinol in anginaISRCTN15253766niversity of Dundee (UK)88
Not yet recruiting
Not Applicable
Treatment of Oral Submucous Fibrosis with Xanthinol Nicotinate, Dexamethasone and Levamisole.CTRI/2019/05/019008Dr Shaikh Saba Sultana
Active, not recruiting
Phase 1
Allopurinol, brain lesions, heart size and blood pressure after ischaemic strokeEUCTR2013-004235-77-GBHS Greater Glasgow & Clyde464
Completed
Not Applicable
Do Xanthine Oxidase Inhibitors (XOI) have clinically useful anti-ischaemic effects in the treatment of angina pectoris? A double-blind, placebo controlled trialCoronary Artery Disease - patients with chronic stable anginaCirculatory SystemCoronary Artery DiseaseISRCTN82040078niversity of Dundee (UK)60
Recruiting
Phase 3
Investigating the effect of quince oxymel on non-alcoholic fatty liveron-alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20221202056689N1Ghoum University of Medical Sciences80